Figures & data
Table I. Patients' characteristics.
Table II. Dose levels examined (mg/m2).
Table III. Planned and administered doses (mg/m2/week) per patient and dose level.
Table IV. Hematologic toxicity per cycle and dose-level (n = 121).
Table V. Non-hematologic toxicity per patient and dose-level (n = 21).